precision-medicine

Scientific Reports, Published online: 24 April 2026; doi:10.1038/s41598-026-49122-w An ensemble-based sentiment analysis approach for precision medicine recommendation

The Keck School of Medicine of USC and Keck Medicine of USC have launched collaborations with Tempus AI, Inc., a technology company at the forefront of applying AI to precision medicine, to integrate clinical care, clinical trials and research through a unified framework.

A quiet revolution is underway in modern medicine: Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies.

The Kaiser Permanente Genomic Oncology program is one of the largest known community-based precision oncology and genomic testing programs in the U.S. The post Precision treatments personalize care for people with cancer appeared first on Kaiser Permanente Division of Research .

This Nature Conference brings together leaders across science, medicine and policy to ask a simple question: how do we make truly personalised care in the next decade the norm, not the exception?

Precision medicine—an approach to disease treatment that tailors care based on each person’s unique genetic makeup, environment, and lifestyle—is changing how cancer is treated around the world. But in Latin America, making this approach available to everyone still faces major obstacles. A new study by Dr. Ana Rita González from Policy Wisdom LLC and her team outlines how precision medicine could…

The Program for Precision Medicine reflects on achievements across research, education and patient care missions since its launch 2019 in this comprehensive report. The post Program for Precision Medicine Celebrates Phase One appeared first on Department of Genetics .

In a sense, all care strives to be tailored to the individual patient. But the technical possibilities to obtain large amounts of biological data from individuals have increased so significantly that today one is talking about a paradigm shift and a new way of working with disease: precision medicine. Instead of giving all patients with […] The post What does precision medicine and AI mean for th…

Biomarkers & Precision Medicine US takes place on October 27 - 28 in San Francisco, CA. Running across two full days, with 15 tracks across three dedicated programmes it's the must attend event for those involved in bringing next-generation personalized treatments to market.

A breakthrough in the science used to customize the treatment of cancer and other diseases is so promising that researchers… Read More

In order to produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells both within and across different tumors because those differences impact how tumors respond to treatment. Part of this work requires a deep understanding of the RNA or protein molecules each cancer cell expresses, where […]

Biomarkers and Precision Medicine 2025 is an immersive event now in its 20th year, spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated programmes […]

Our recent study in Nature Scientific Reports identified key challenges in the biomedical data lifecycle and offered 7 actionable recommendations. The post Advancing biomedical discovery: Overcoming data challenges in precision medicine appeared first on Microsoft Research .

NVIDIA’s contributions to accelerating medical imaging, genomics, computational chemistry and AI-powered robotics were honored Friday at the Precision Medicine World Conference in Santa Clara, California, where NVIDIA founder and CEO Jensen Huang received a Luminary award. The Precision Medicine World Conference brings together healthcare leaders, top global researchers and innovators across biot…

Axel Constant on whether there are alternatives to reductionism in precision psychiatry The post The Promise of Precision Medicine | Axel Constant appeared first on BSPS .

The dynamic world of proteomics is shaping the future of personalised medicine, but some obstacles stand in the way

The post NIH podcast features Peter O’Dwyer and Lyndsay Harris on the profound impacts of precision medicine and genomic sequencing on cancer care appeared first on ECOG-ACRIN Cancer Research Group .

A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine.

Jonathan Berg, MD, PhD, Distinguished Professor of Genetics and Medicine at the UNC School of Medicine, is a principal investigator of The Clinical Genome Resource, a multi-institution consortium initially launched in 2013 by the National Human Genome Research Institute to provide evidence-based evaluations of clinically relevant genes and variants. The post UNC Awarded $24-million NIH Grant to I…